miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer

Atonal homolog 1 expression in lung cancer correlates with inhibitors of the Wnt pathway as well as the differentiation and primary tumor stage

(2012) Hong-Tao Xu et al.   APMIS

MiR-93 enhances angiogenesis and metastasis by targeting LATS2

(2012) Ling Fang et al.   CELL CYCLE

Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells

(2012) Xin Fu et al.   FEBS LETTERS

miR-93/Sp7 function loop mediates osteoblast mineralization

(2012) Li Yang et al.   JOURNAL OF BONE AND MINERAL RESEARCH

miR-93/106b and Their Host Gene,MCM7, Are Differentially Expressed in Leiomyomas and Functionally TargetF3andIL-8

(2012) Tsai-Der Chuang et al.   MOLECULAR ENDOCRINOLOGY

The miR-106b-25 cluster targets Smad7, activates TGF-β signaling and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer

(2012) A L Smith et al.   ONCOGENE

Rapid Generation of MicroRNA Sponges for MicroRNA Inhibition

(2012) Joost Kluiver et al.   PLoS One

miR-337-3p and Its Targets STAT3 and RAP1A Modulate Taxane Sensitivity in Non-Small Cell Lung Cancers

(2012) Liqin Du et al.   PLoS One

Cell-Free MicroRNA Expression Profiles in Malignant Effusion Associated with Patient Survival in Non-Small Cell Lung Cancer

(2012) Tingting Wang et al.   PLoS One

Repression of human activation induced cytidine deaminase by miR-93 and miR-155

(2011) Glen M Borchert et al.   BMC CANCER

Disabled-2 and Axin are concurrently colocalized and underexpressed in lung cancers

(2011) Hong-Tao Xu et al.   HUMAN PATHOLOGY

miR-145 is differentially regulated by TGF-β1 and ischaemia and targets Disabled-2 expression and wnt/β-catenin activity

(2011) Maritza E. Mayorga et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs

(2011) David M Garcia et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2

(2011) A Chao et al.   ONCOGENE

Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer

(2011) K Kim et al.   ONCOGENE

Identification of MicroRNA-93 as a Novel Regulator of Vascular Endothelial Growth Factor in Hyperglycemic Conditions

(2010) Jianyin Long et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Epigenetic downregulation of human disabled homolog 2 switches TGF-β from a tumor suppressor to a tumor promoter

(2010) Adèle Hannigan et al.   JOURNAL OF CLINICAL INVESTIGATION

MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8

(2010) L Fang et al.   ONCOGENE

Role of themiR-106b-25microRNA cluster in hepatocellular carcinoma

(2009) Yang Li et al.   CANCER SCIENCE

miR-93, miR-98, and miR-197 Regulate Expression of Tumor Suppressor Gene FUS1

(2009) L. Du et al.   MOLECULAR CANCER RESEARCH

Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer

(2009) Young-Kook Kim et al.   NUCLEIC ACIDS RESEARCH

miR-221 overexpression contributes to liver tumorigenesis

(2009) P. Pineau et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

E2F1-Regulated MicroRNAs Impair TGFβ-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer

(2008) Fabio Petrocca et al.   CANCER CELL

Roles for MicroRNAs, miR-93 and miR-130b, and Tumor Protein 53–Induced Nuclear Protein 1 Tumor Suppressor in Cell Growth Dysregulation by Human T-Cell Lymphotrophic Virus 1

(2008) Man Lung Yeung et al.   CANCER RESEARCH

Loss and Reduction of Fus1 Protein Expression is a Frequent Phenomenon in the Pathogenesis of Lung Cancer

(2008) L. Prudkin et al.   CLINICAL CANCER RESEARCH

Most mammalian mRNAs are conserved targets of microRNAs

(2008) R. C. Friedman et al.   GENOME RESEARCH